Cargando…
SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis
The full epigenetic repertoire governing breast cancer metastasis is not completely understood. Here, we discuss the histone methyltransferase SET Domain Bifurcated Histone Lysine Methyltransferase 1 (SETDB1) and its role in breast cancer metastasis. SETDB1 serves as an exemplar of the difficulties...
Autores principales: | Batham, Jacob, Lim, Pek Siew, Rao, Sudha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721492/ https://www.ncbi.nlm.nih.gov/pubmed/31405032 http://dx.doi.org/10.3390/cancers11081143 |
Ejemplares similares
-
SETDB1 regulates SMAD7 expression for breast cancer metastasis
por: Ryu, Tae Young, et al.
Publicado: (2019) -
Epigenetic mechanism of SETDB1 in brain: implications for neuropsychiatric disorders
por: Zhu, Yueyan, et al.
Publicado: (2020) -
Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response
por: McGoverne, Isabella, et al.
Publicado: (2020) -
SETDB1 regulates microtubule dynamics
por: Hernandez‐Vicens, Rosari, et al.
Publicado: (2022) -
SETDB1-Mediated Silencing of Retroelements
por: Fukuda, Kei, et al.
Publicado: (2020)